Williams TM - Search Results

1

A novel kinase inhibitor of FADD phosphorylation chemosensitizes through the inhibition of NF-κB.

Schinske KA, Nyati S, Khan AP, Williams TM, Johnson TD, Ross BD, Tomás RP, Rehemtulla A. Schinske KA, et al. Among authors: williams tm. Mol Cancer Ther. 2011 Oct;10(10):1807-17. doi: 10.1158/1535-7163.MCT-11-0362. Epub 2011 Aug 22. Mol Cancer Ther. 2011. PMID: 21859840 Free PMC article.

2

Cotargeting MAPK and PI3K signaling with concurrent radiotherapy as a strategy for the treatment of pancreatic cancer.

Williams TM, Flecha AR, Keller P, Ram A, Karnak D, Galbán S, Galbán CJ, Ross BD, Lawrence TS, Rehemtulla A, Sebolt-Leopold J. Williams TM, et al. Mol Cancer Ther. 2012 May;11(5):1193-202. doi: 10.1158/1535-7163.MCT-12-0098. Epub 2012 Mar 12. Mol Cancer Ther. 2012. PMID: 22411900 Free PMC article.

3

DW-MRI as a biomarker to compare therapeutic outcomes in radiotherapy regimens incorporating temozolomide or gemcitabine in glioblastoma.

Galbán S, Lemasson B, Williams TM, Li F, Heist KA, Johnson TD, Leopold JS, Chenevert TL, Lawrence TS, Rehemtulla A, Mikkelsen T, Holland EC, Galbán CJ, Ross BD. Galbán S, et al. Among authors: williams tm. PLoS One. 2012;7(4):e35857. doi: 10.1371/journal.pone.0035857. Epub 2012 Apr 20. PLoS One. 2012. PMID: 22536446 Free PMC article.

4

DW-MRI as a Predictive Biomarker of Radiosensitization of GBM through Targeted Inhibition of Checkpoint Kinases.

Williams TM, Galbán S, Li F, Heist KA, Galbán CJ, Lawrence TS, Holland EC, Thomae TL, Chenevert TL, Rehemtulla A, Ross BD. Williams TM, et al. Transl Oncol. 2013 Apr;6(2):133-42. doi: 10.1593/tlo.13214. Epub 2013 Apr 1. Transl Oncol. 2013. PMID: 23544166 Free PMC article.

5

A multi-institutional phase 2 study of neoadjuvant gemcitabine and oxaliplatin with radiation therapy in patients with pancreatic cancer.

Kim EJ, Ben-Josef E, Herman JM, Bekaii-Saab T, Dawson LA, Griffith KA, Francis IR, Greenson JK, Simeone DM, Lawrence TS, Laheru D, Wolfgang CL, Williams T, Bloomston M, Moore MJ, Wei A, Zalupski MM. Kim EJ, et al. Cancer. 2013 Aug 1;119(15):2692-700. doi: 10.1002/cncr.28117. Epub 2013 May 29. Cancer. 2013. PMID: 23720019 Free PMC article. Clinical Trial.

6

Molecular imaging of the ATM kinase activity.

Williams TM, Nyati S, Ross BD, Rehemtulla A. Williams TM, et al. Int J Radiat Oncol Biol Phys. 2013 Aug 1;86(5):969-77. doi: 10.1016/j.ijrobp.2013.04.028. Epub 2013 May 29. Int J Radiat Oncol Biol Phys. 2013. PMID: 23726004 Free PMC article.

7

A Genome-Wide Pooled shRNA Screen Identifies PPP2R2A as a Predictive Biomarker for the Response to ATR and CHK1 Inhibitors.

Qiu Z, Fa P, Liu T, Prasad CB, Ma S, Hong Z, Chan ER, Wang H, Li Z, He K, Wang QE, Williams TM, Yan C, Sizemore ST, Narla G, Zhang J. Qiu Z, et al. Among authors: williams tm. Cancer Res. 2020 Aug 15;80(16):3305-3318. doi: 10.1158/0008-5472.CAN-20-0057. Epub 2020 Jun 10. Cancer Res. 2020. PMID: 32522823 Free PMC article.

8

MEK inhibitor GSK1120212-mediated radiosensitization of pancreatic cancer cells involves inhibition of DNA double-strand break repair pathways.

Estrada-Bernal A, Chatterjee M, Haque SJ, Yang L, Morgan MA, Kotian S, Morrell D, Chakravarti A, Williams TM. Estrada-Bernal A, et al. Among authors: williams tm. Cell Cycle. 2015;14(23):3713-24. doi: 10.1080/15384101.2015.1104437. Cell Cycle. 2015. PMID: 26505547 Free PMC article.

9

IL-21 Enhances Natural Killer Cell Response to Cetuximab-Coated Pancreatic Tumor Cells.

McMichael EL, Jaime-Ramirez AC, Guenterberg KD, Luedke E, Atwal LS, Campbell AR, Hu Z, Tatum AS, Kondadasula SV, Mo X, Tridandapani S, Bloomston M, Ellison EC, Williams TM, Bekaii-Saab T, Carson WE 3rd. McMichael EL, et al. Among authors: williams tm. Clin Cancer Res. 2017 Jan 15;23(2):489-502. doi: 10.1158/1078-0432.CCR-16-0004. Epub 2016 Jul 19. Clin Cancer Res. 2017. PMID: 27435400 Free PMC article.

10

LCL161, a SMAC-mimetic, Preferentially Radiosensitizes Human Papillomavirus-negative Head and Neck Squamous Cell Carcinoma.

Yang L, Kumar B, Shen C, Zhao S, Blakaj D, Li T, Romito M, Teknos TN, Williams TM. Yang L, et al. Among authors: williams tm. Mol Cancer Ther. 2019 Jun;18(6):1025-1035. doi: 10.1158/1535-7163.MCT-18-1157. Epub 2019 Apr 23. Mol Cancer Ther. 2019. PMID: 31015310 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

540 results

Search Page